Latest news
ICONOVO IS NOW TAX REGISTERED IN INDIA
Another step for Iconovo in our dedication to do business in India.
ICONOVO HAS A NEW GRANTED PATENT
The Swedish Patent and Registration Office, PRV, has granted a new patent for ICOres. SE 539 930 C2. Another milestone for this inventive inhaler.
Press releases
Feb 12, 2026, 08:30
News
IR
English
Regulatory
MAR
Report
Interim
Yearend
Feb 12, 2026, 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Yearend
Jan 15, 2026, 10:15
News
IR
English
Corporate Action
Other
mfn-ext-nq
mfn-ext-nq-corporate-action
Jan 15, 2026, 10:15
News
IR
Swedish
Corporate Action
Other
mfn-ext-nq
mfn-ext-nq-corporate-action
Jan 13, 2026, 13:40
News
IR
English
Corporate Action
Other
mfn-ext-nq
mfn-ext-nq-corporate-action
Jan 13, 2026, 13:40
News
IR
Swedish
Corporate Action
Other
mfn-ext-nq
mfn-ext-nq-corporate-action
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 62 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
Director Business Development and Alliances
Måns Österberg
Mail: mans.osterberg@iconovo.se
CEO
Anders Månsson
Mail: anders.mansson@iconovo.se
Press releases
Follow us on Linkedin
